EP4331607
Föst lyfjasamsetning sem inniheldur 2-{4-[N-(5,6-dífenýlpýrasín-2-ýl)-N-ísóprópýlamínó]bútýloxý}-N-(metýlsúlfónýl)asetamíð
Status:
EP einkaleyfi: Leiðrétt þýðing á staðfestu EP einkaleyfiEP appl. date:
1.12.2016EP published:
30.4.2025EP application number:
23214939.3
EP translation filed:
21.5.2025Grant published:
15.6.2025EPO information:
European Patent Register
Max expiry date:
30.11.2036Expiry date:
30.11.2026Next due date:
30.12.2026
Title in English:
SOLID PHARMACEUTICAL COMPOSITION CONTAINING 2-{4-[N-(5,6-DIPHENYLPYRAZIN-2-YL)-N-ISOPROPYLAMINO]BUTYLOXY}-N-(METHYLSULFONYL)ACETAMIDELanguage of the patent:
English
Timeline
Today
1.12.2016EP application
30.4.2025EP Publication
21.5.2025Translation submitted
15.6.2025Registration published
30.11.2026Expires
Owner
Name:
Nippon Shinyaku Co., Ltd.Address:
14, Kisshoin Nishinosho Monguchicho Minami-ku, Kyoto-shi Kyoto 601-8550, JP
Inventor
Name:
FURUTA, ShoujiAddress:
Kyoto-Shi, Kyoto 601-8550, JP
Name:
MUKAI, HironoriAddress:
Kyoto-Shi, Kyoto 601-8550, JP
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
2015236034Date:
2.12.2015Country:
JP
Classification
Categories:
A61K 31/4965, A61K 9/16, A61K 9/20, A61P 7/02, A61P 9/10, A61P 9/12, A61P 11/00, A61P 13/12, A61P 11/06
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 24.11.2025
Expires: 30.11.2026
Payer: Árnason Faktor ehf.